<SEC-DOCUMENT>0001104659-21-122325-index.html : 20211004
<SEC-HEADER>0001104659-21-122325.hdr.sgml : 20211004
<ACCEPTANCE-DATETIME>20211004085421
ACCESSION NUMBER:		0001104659-21-122325
CONFORMED SUBMISSION TYPE:	SC 13G
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20211004
DATE AS OF CHANGE:		20211004
GROUP MEMBERS:		ROCHE HOLDING LTD

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Jasper Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001788028
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				842984849
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-91228
		FILM NUMBER:		211301158

	BUSINESS ADDRESS:	
		STREET 1:		2200 BRIDGE PKWY SUITE #102
		CITY:			REDWOOD CITY
		STATE:			CA
		ZIP:			94065
		BUSINESS PHONE:		6505491400

	MAIL ADDRESS:	
		STREET 1:		2200 BRIDGE PKWY SUITE #102
		CITY:			REDWOOD CITY
		STATE:			CA
		ZIP:			94065

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Amplitude Healthcare Acquisition Corp
		DATE OF NAME CHANGE:	20190912

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ROCHE FINANCE LTD
		CENTRAL INDEX KEY:			0001053942
		STATE OF INCORPORATION:			V8

	FILING VALUES:
		FORM TYPE:		SC 13G

	BUSINESS ADDRESS:	
		STREET 1:		C/O HOFFMAN LA ROCHE
		STREET 2:		124 GRENSACHERSTRASSE CH 4002
		CITY:			BASEL SWITZERLAND
		STATE:			V8

	MAIL ADDRESS:	
		STREET 1:		C/O HOFFMAN LA ROCHE
		STREET 2:		124 GRENSACHERSTRASSE CH 4002
		CITY:			BASEL SWITZERLAND
		STATE:			V8
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G
<SEQUENCE>1
<FILENAME>tm2129153d1_sc13g.htm
<DESCRIPTION>SC 13G
<TEXT>
Document 1 - file: tm2129153d1_sc13g.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tm2129153d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
Document 2 - file: tm2129153d1_ex99-1.htm

</DOCUMENT>
</SEC-DOCUMENT>